Over the last four years (2011 to 2014), the percentages of Klebsiella pneumonia e resistant to fluoroquinolones, third-generation cephalosporins and aminoglycosides, as well as combined resistance to all three antimicrobial groups, has increased significantly at the EU/EEA level.

This is the first annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) after the transition of the European Antimicrobial Resistance Surveillance System (EARSS) to ECDC on 1 January 2010.

This report presents antimicrobial resistance data reported to EARS-Net by 28 countries for 2010 with trend analyses for the period 2007-2010. This edition also includes a focus chapter on carbapenem-resistant K. pneumoniae and P. aeruginosa.

This report is based on data for 2014 retrieved from The European Surveillance System (TESSy) on 19 February 2018.

EARS-Net data for 2017 show that antimicrobial resistance remains a serious threat in Europe.

This report is based on data for 2015 retrieved from The European Surveillance System (TESSy) on 19 February 2018.

This report is based on data for 2016 retrieved from The European Surveillance System (TESSy) on 19 February 2018.

This report presents antimicrobial resistance data for seven microorganisms of major public health importance. For 2015, data were reported by 29 countries. The report also presents trend analyses for the period 2012–2015.

This report presents antimicrobial resistance data for seven microorganisms of major public health importance: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter species, Streptococcus pneumoniae, Staphylococcus aureus, and Enterococci.

Twenty-seven countries, comprising 25 EU Member States and two EEA countries (Iceland and Norway) reported data on antimicrobial consumption for 2017.